요약문 / 1
제1장 제약산업 특성 및 정책 동향 / 13
1. 의약품 및 제약산업 정의 ······································································ 13
2. 국내 제약산업 특성 ··············································································· 16
3. 국내 제약산업의 정책동향 ····································································· 22
4. 코로나19로 인한 제약산업 영향 ··························································· 26
5. 국내 제약기업(혁신형 제약기업 위주) 주요 실적 ································ 35
제2장 세계 제약산업 동향 / 41
1. 세계 의약품 시장 동향 ·········································································· 41
2. 국가별 시장 동향 ··················································································· 50
3. 전 세계 의약품 연구개발 동향 ····························································· 59
제3장 국내 제약산업 동향 / 67
1. 우리나라 제약산업 동향 ········································································ 67
2. 수출입 동향 ···························································································· 80
3. 바이오의약품 동향 ················································································· 85
제4장 국내 제약산업 연구개발 동향 / 91
1. 개요 ········································································································· 91
2. 제약산업 기업체 연구개발 현황 ···························································· 92
제5장 결언 / 103
1. 산업동향 ······························································································· 103
2. 산업전망 및 함의 ················································································· 106
3. 맺음말 ··································································································· 117
참고문헌 / 118
부록 / 123
1. 국내 의약품 생산실적 ·········································································· 123
2. 국내 의약품 시장현황 ·········································································· 124
3. 세계 상위 20개 제약업체 매출액 현황 ·············································· 125
4. 의약품 제조·수출입 허가 및 신고 현황 ·············································· 126
5. 2019년 국가별 의약품 수출 현황 ······················································· 127
출처: 한국보건산업진흥원
요약문 / 1
제1장 제약산업 특성 및 정책 동향 / 13
1. 의약품 및 제약산업 정의 ······································································ 13
2. 국내 제약산업 특성 ··············································································· 16
3. 국내 제약산업의 정책동향 ····································································· 22
4. 코로나19로 인한 제약산업 영향 ··························································· 26
5. 국내 제약기업(혁신형 제약기업 위주) 주요 실적 ································ 35
제2장 세계 제약산업 동향 / 41
1. 세계 의약품 시장 동향 ·········································································· 41
2. 국가별 시장 동향 ··················································································· 50
3. 전 세계 의약품 연구개발 동향 ····························································· 59
제3장 국내 제약산업 동향 / 67
1. 우리나라 제약산업 동향 ········································································ 67
2. 수출입 동향 ···························································································· 80
3. 바이오의약품 동향 ················································································· 85
제4장 국내 제약산업 연구개발 동향 / 91
1. 개요 ········································································································· 91
2. 제약산업 기업체 연구개발 현황 ···························································· 92
제5장 결언 / 103
1. 산업동향 ······························································································· 103
2. 산업전망 및 함의 ················································································· 106
3. 맺음말 ··································································································· 117
참고문헌 / 118
부록 / 123
1. 국내 의약품 생산실적 ·········································································· 123
2. 국내 의약품 시장현황 ·········································································· 124
3. 세계 상위 20개 제약업체 매출액 현황 ·············································· 125
4. 의약품 제조·수출입 허가 및 신고 현황 ·············································· 126
5. 2019년 국가별 의약품 수출 현황 ······················································· 127
출처: 한국보건산업진흥원
2020 제약산업 분석보고서.pdf